Relaxin-2 May Suppress Endometriosis by Reducing Fibrosis, Scar Formation, and Inflammation

Background: Relaxin (RLX)-2, produced by the corpus luteum and placenta, is known to be potentially effective in fibrotic diseases of the heart, lungs, kidneys, and bladder; however, its effectiveness in endometriosis has not yet been investigated. In the present study, we conducted a comprehensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshino, Osamu, Ono, Yosuke, Honda, Masako, Hattori, Kyoko, Sato, Erina, Hiraoka, Takehiro, Ito, Masami, Kobayashi, Mutsumi, Arai, Kenta, Katayama, Hidekazu, Tsuchida, Hiroyoshi, Yamada-Nomoto, Kaori, Iwahata, Shunsuke, Fukushi, Yoshiyuki, Wada, Shinichiro, Iwase, Haruko, Koga, Kaori, Osuga, Yutaka, Iwaoka, Michio, Unno, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693148/
https://www.ncbi.nlm.nih.gov/pubmed/33142814
http://dx.doi.org/10.3390/biomedicines8110467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693148/
https://www.ncbi.nlm.nih.gov/pubmed/33142814
http://dx.doi.org/10.3390/biomedicines8110467

Ejemplares similares